Читать книгу Biological Mechanisms of Tooth Movement - Группа авторов - Страница 48

At the leading side of the tooth, removal of the necrotic tissue is accompanied by an influx of differentiating fibroblasts, which secrete new ECM (Figure 3.12). This migration is probably stimulated by periostin, an ECM protein that is expressed in periodontal tissues subjected to continuous mechanical stress (Cobo et al., 2016).

Figure 3.12 Summary of the remodeling processes at the leading side. Fibroblasts (1) under compressive strain secrete IL‐1 and IL‐6 which under these conditions upregulate the expression of the ligand for the receptor activator of nuclear factor kappa‐B (RANKL) (2) and MMPs (3) The MMPs degrade the ECM of the PDL and the osteoid (4), and RANKL stimulates the differentiation and activation of osteoclasts (5).

(Source Meikle, 2006. Reproduced with permission of Oxford University Press.)

In contrast to the normal PDL, the newly formed ECM contains mainly collagen type III instead of collagen type I. Similarly to collagen type I, type III collagen is a fibrillar collagen. It is a homotrimer containing three α1(III) chains forming a triple helix. It is rapidly produced by young fibroblasts and other mesenchymal cells in granulation tissue, and in other areas where rapid tissue formation is essential.

Simultaneously, capillaries, that are quickly recruited through endothelial cell proliferation, capillary enlargement, and elongation, restore the vasculature of the PDL. This process is mediated through VEGFs, which are synthesized and secreted by a variety of cells, such as mast cells, macrophages, and fibroblasts. Binding of circulating VEGF to VEGF receptors on endothelial cells triggers the pathway leading to angiogenesis (Salomão et al., 2014; Tsuge et al., 2016; Militi et al., 2019).

At the trailing side of the tooth, the proinflammatory cytokine IL‐1β and pentraxin‐ related protein (PTX3) are secreted shortly after force application by mononuclear phagocytes, fibroblasts, and endothelial cells throughout the PDL. PTX3 is involved in tissue remodeling and repair in sterile conditions (Tsuge et al., 2016).

After the hyalinized tissue is completely removed, the tooth is again surrounded by a vital PDL. At the leading side of the tooth, the PDL contains mainly collagen type III, and at the trailing side it contains newly formed collagen type I as well as type III collagen. The orthodontic force induces negative strain at the leading side, and positive strain at the trailing side. This results in strain of the periodontal fibroblasts. The integrins by which they are attached to the ECM can act as force transducers or “strain gauges” (Chiquet et al., 2003; Chiquet et al., 2007). Furthermore, fluid flow in the PDL, and also within the canalicular network in the alveolar bone, is induced. In addition, this fluid flow induces strain in the cell membranes, not only of the fibroblasts, but also of the osteoblasts and the osteocytes. The osteocytes within the canaliculi of the alveolar bone are important mechanosensors and transducers of applied mechanical strain. Together with osteoblasts and periodontal fibroblasts they contribute to the activation of cells by integrin‐mediated strain transmission to the cytoskeleton and the subsequent induction of the expression of a variety of growth factors and cytokines (Klein‐Nulend et al., 2013; Tresguerres et al., 2020). These factors, such as FGF, IGF‐1, IL‐1α, IL‐1β, IL‐6, and TNFα mediate the differentiation of precursors into osteoblasts and osteoclasts (Eriksen, 2010; Vansant et al., 2018).

For OTM, resorption of the alveolar bone by osteoclasts at the leading side of the tooth is essential. These cells are derived from myeloid precursors that have differentiated into monocytes and subsequently into osteoclast precursors through macrophage colony‐stimulating factor (M‐CSF). Their further differentiation is dependent on the ligand for the receptor activator of nuclear factor kappa‐B (RANKL) that is secreted by fibroblasts and osteoblasts. RANKL binds to RANK, expressed on the osteoclast precursors that subsequently become mononuclear osteoclasts, characterized by the expression of tartrate resistant acid phosphatase (TRAP). After fusion, these cells become multinuclear osteoclasts (Suda et al., 1999; Yamaguchi, 2009; Vansant et al., 2018). The differentiation of osteoclasts is counteracted by osteoprotegerin (OPG). This is a soluble decoy receptor for RANKL. This means that binding of OPG to RANKL inhibits the binding of RANKL to RANK on the osteoclast precursors and thus hampers both the further differentiation and the functioning of osteoclasts. Interestingly, strain affects both the secretion of RANKL and the secretion of OPG (Figure 3.13).

At the leading side of the tooth the negative strain stimulates the secretion of RANKL, but decreases the secretion of OPG, and thus the differentiation and functioning of osteoclasts are stimulated. On the other hand, in the areas with positive strain, the trailing side of the tooth, RANKL as well as OPG are upregulated, but OPG is more upregulated than RANKL, and thus osteoclast differentiation is prevented (Hadjidakis and Androulakis, 2006; Yamaguchi, 2009; Vansant et al., 2018).

For the functioning of osteoclasts, they should be attached to mineralized bone matrix through αVβ3 integrin. This is only possible when the osteoblasts, as well as the osteoid, the nonmineralized bone matrix covering the surface of the alveolar bone, are removed (Duong et al., 2000; Takahashi et al., 2007; Eriksen, 2010). The ECM of the osteoid is degraded through the action of MMPs, more specifically the collagenases MMP1, MMP8, MMP13, and MMP14 (Tokuhara et al., 2019). These enzymes are synthetized and secreted as pro‐enzymes by a variety of cell types, including lymphocytes and granulocytes, but in particular by activated macrophages. They are activated by proteolytic cleavage and regulated by a family of inhibitors called the tissue inhibitors of matrix metalloproteinases (TIMPs). The MMP activity is thus dependent on the balance between production and activation of MMPs and the local levels of TIMPs (Snoek‐van Beurden and Von den Hoff, 2005; Verstappen and Von den Hoff, 2006; Tokuhara et al., 2019). The osteoblasts disappear by apoptosis (programmed cell death), induced by binding of TNF‐α (that is secreted by activated macrophages, fibroblasts, and osteoblasts, in an autocrine way) to its receptors TNFR1 and TNFR2 on osteoblasts and the subsequent activation of the caspase pathway (Hill et al., 1997; Jilka et al., 1998; Hock et al., 2001).

The combined osteoblast apoptosis and ECM degradation leads to areas of exposure of mineralized bone matrix, which can serve as landing sites for osteoclasts. The osteoclasts move to the landing sites by chemotaxis, and attach to the bone by αVβ3 integrins, connecting the osteoclast to RGD peptides in the bone matrix (Takahashi et al., 2007; Lerner et al., 2019). Upon adhesion to bone, osteoclasts polarize and reorganize their cytoskeleton to generate a ring‐like F‐actin‐rich structure, the sealing zone, that isolates the Howship’s lacuna from the surroundings. Inside the sealing zone, the ruffled border is formed. The isolated area becomes acidic through an H⁺‐ATPase‐mediated proton pump. This favors the dissolution of bone minerals. In addition, the lysosomal enzyme cathepsin K, a cysteine proteinase with a pH optimum of 4.5, and matrix metalloproteinases, especially MMP‐9 (pH optimum = 7.4) are secreted into Howship’s lacunae to degrade the organic bone matrix (Teitelbaum, 2000) (Figure 3.14).

Figure 3.13 The RANK/RANKL/OPG system. The RANKL that is secreted by fibroblasts and osteoblasts binds to RANK, expressed on the osteoclast precursors. The latter subsequently become mononuclear osteoclasts. After fusion, these cells become multinuclear osteoclasts. However, fibroblasts and osteoblasts also can secrete osteoprotegerin (OPG), a soluble factor that also binds to RANKL, thereby hampering the differentiation of osteoclasts.

(Source: Jaap Maltha.)

Figure 3.14 An active osteoclast.

(Source: Jaap Maltha.)

At the trailing side of the moving tooth, the PDL is widened, accompanied with a positive strain in the ECM and an acute inflammatory reaction (Figure 3.15). This results in an increase in IL‐1β, IL‐10, PGE2, and TGF‐β expression (Tsuge et al., 2016; Li et al., 2018), and subsequently in an increase in OPG and a decrease in RANKL secretion by the osteoblasts and periodontal fibroblast (Li et al., 2018).

Figure 3.15 Summary of the remodeling processes at the trailing side. Fibroblasts under tensile strain secrete IL‐1 and IL‐6 (1), which in turn stimulate MMPs and inhibit TIMPs (2). Fibroblasts also secrete VEGF that stimulates angiogenesis (3). These actions result together in anabolic activities of fibroblasts (4) and osteoblasts (5).

(Source Meikle, 2006. Reproduced with permission of Oxford University Press.)

Furthermore, the number of fibroblasts increases, and the secretion of collagen type I and collagen type III, as well as the formation of new Sharpey’s fibers, is stimulated. Simultaneously with the deposition of the Sharpey’s fibers, osteoblasts deposit new bone matrix on the adjacent alveolar bone socket wall, anchoring the Sharpey’s fibers in the bone matrix (Garant and Cho, 1979; Militi et al., 2019). On the other hand, the expression of MMPs is downregulated and the expression of TIMPs is upregulated, and thus ECM breakdown is inhibited.

Finally, FGF‐2 and VEGF, growth factors involved in the development of vascular elements, are upregulated (Chen et al., 2014; Salomão et al., 2014; Li et al., 2018; Militi et al., 2019).

The cumulative result is that at the trailing side osteoclast differentiation is prevented, the formation of new ECM and bone deposition is stimulated, and adaptation of the vascular system to the new situation is induced.